We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+7.58%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$2.41B
AUM Growth
-$3.75B
Cap. Flow
-$4.09B
Cap. Flow %
-169.35%
Top 10 Hldgs %
31.78%
Holding
6,989
New
537
Increased
1,702
Reduced
3,620
Closed
686

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$145M
2
TSM icon
TSMC
TSM
+$120M
3
VOO icon
Vanguard S&P 500 ETF
VOO
+$37.4M
4
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$14.5M
5
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$9.96M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$322M
2
MSFT icon
Microsoft
MSFT
+$269M
3
AMZN icon
Amazon
AMZN
+$128M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$107M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$80.6M

Sector Composition

Rank Sector Weight
1 Technology 21.73%
2 Healthcare 7.71%
3 Consumer Discretionary 6.84%
4 Financials 6.55%
5 Industrials 4.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PTRS
3776
DELISTED
Partners Bancorp Common Stock
PTRS
$12K ﹤0.01%
1,348
-204
-13% -$1.81K
FOCS
3777
DELISTED
Focus Financial Partners Inc. Class A
FOCS
$12K ﹤0.01%
340
-10,087
-97% -$359K
DMS
3778
DELISTED
Digital Media Solutions, Inc.
DMS
$12K ﹤0.01%
612
-94
-13% -$2.36K
HMPT
3779
DELISTED
Home Point Capital, Inc Common Stock
HMPT
$12K ﹤0.01%
8,769
-3,440
-28% -$5.3K
SUMO
3780
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
$12K ﹤0.01%
1,428
-7,097
-83% -$54K
JNCE
3781
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$12K ﹤0.01%
10,472
+2,895
+38% +$4.12K
OIG
3782
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$12K ﹤0.01%
+1,517
New +$17.4K
NVIV
3783
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
$12K ﹤0.01%
5,147
+3,395
+194% +$8.51K
ACNB icon
3784
ACNB Corp
ACNB
$660M
$11K ﹤0.01%
275
-1,699
-86% -$62K
ADCT icon
3785
ADC Therapeutics
ADCT
$129M
$11K ﹤0.01%
2,935
-6,538
-69% -$26.1K
ALNT icon
3786
Allient
ALNT
$1.89B
$11K ﹤0.01%
311
-483
-61% -$15.9K
GOLD
3787
Gold.com Inc
GOLD
$1.28B
$11K ﹤0.01%
316
-1,942
-86% -$61.4K
APCX
3788
DELISTED
AppTech Payments
APCX
$11K ﹤0.01%
4,710
-4,884
-51% -$4.51K
AZZ icon
3789
AZZ Inc
AZZ
$4.55B
$11K ﹤0.01%
281
-2,099
-88% -$82.5K
BOND icon
3790
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.47B
$11K ﹤0.01%
+118
New +$10.6K
BRTX icon
3791
BioRestorative Therapies
BRTX
$5.76M
$11K ﹤0.01%
4,181
+1,927
+85% +$6K
BTAI icon
3792
BioXcel Therapeutics
BTAI
$36.7M
$11K ﹤0.01%
31
-47
-60% -$11.4K
CCS icon
3793
Century Communities
CCS
$2.01B
$11K ﹤0.01%
225
-2,213
-91% -$105K
CLW icon
3794
Clearwater Paper
CLW
$345M
$11K ﹤0.01%
279
-1,619
-85% -$63.1K
CNSP icon
3795
CNS Pharmaceuticals
CNSP
$8.07M
– –
0
– –
CNXN icon
3796
PC Connection
CNXN
$2.05B
$11K ﹤0.01%
233
-522
-69% -$26.2K
CRBG icon
3797
Corebridge Financial
CRBG
$15.4B
$11K ﹤0.01%
+548
New +$11.6K
CRDL
3798
Cardiol Therapeutics
CRDL
$207M
$11K ﹤0.01%
22,456
+18,926
+536% +$11.5K
CRVS icon
3799
Corvus Pharmaceuticals
CRVS
$1.25B
$11K ﹤0.01%
12,718
+1,050
+9% +$929
CSTL icon
3800
Castle Biosciences
CSTL
$905M
$11K ﹤0.01%
465
-1,356
-74% -$31.4K
150 151
152
153 154

Similar funds

AA
Advisory Alpha Holland, Michigan $4.08B AUM 20.62% 1-Year Est. Return
PL
Plancorp LLC Saint Louis, Missouri $4.1B AUM 25.19% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $4.1B AUM 28.59% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $4.06B AUM 24.91% 1-Year Est. Return
BHC
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.11B AUM 44.45% 1-Year Est. Return
RSWM
Robertson Stephens Wealth Management San Francisco, California $4.06B AUM 32.22% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $4.11B AUM 21.98% 1-Year Est. Return
GCC
Guardian Capital (Canada) Toronto, Ontario, Canada $4.11B AUM 27.59% 1-Year Est. Return

Tower Research Capital (TRC)'s Q4 2022 Portfolio in Review

As of Q4 2022, Tower Research Capital (TRC) held 6,989 positions worth $2.41B, down 61% from $6.16B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.09B in Q4 2022, closing 686 positions and reducing 3,620 holdings. Its most notable exit was Vanguard Russell 2000 Value ETF, an estimated $4.46M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Semiconductor ETF worth $9.33M.

  • Tower Research Capital (TRC)'s largest Q4 2022 buy was iShares Semiconductor ETF: 80,454 shares worth $9.33M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2022, an estimated $145M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2022 reduction was Apple, cutting an estimated $322M.
  • Tower Research Capital (TRC) fully exited Vanguard Russell 2000 Value ETF in Q4 2022, selling an estimated $4.46M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $2.41B portfolio in Q4 2022.
  • Tower Research Capital (TRC) opened 537 new positions and closed 686 in Q4 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 61% quarter-over-quarter to $2.41B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.